Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms

被引:1
|
作者
Lu, Z. [1 ]
Li, T. [2 ,3 ,4 ]
Liu, C. [1 ]
Zheng, Y. [1 ,4 ]
Song, J. [1 ]
机构
[1] Chinese Acad Med Sci, Dept Gen Surg, Dept HepatoBilio Pancreat Surg, Beijing Hosp,Natl Ctr Gerontol,Inst Geriatr Med, 1 DaHua Rd, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Natl Ctr Clin Labs, Beijing Hosp, Natl Ctr Gerontol, 1 Dahua Rd, Beijing 100730, Peoples R China
[3] Chinese Acad Med Sci, Inst Geriatr Med, 1 Dahua Rd, Beijing 100730, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
关键词
Pancreatic neuroendocrine neoplasm; Risk factors; Prediction model; Risk stratification; Cancer-specific survival; TUMORS; GUIDELINES; DIAGNOSIS; MANAGEMENT; CANCER;
D O I
10.1007/s40618-022-01956-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose We explored risk variables associated with cancer-specific survival (CSS) in patients with pancreatic neuroendocrine neoplasms (PNENs) and created a network dynamic nomogram model to predict patient survival time. Methods A total of 7750 patients with PNENs were included in this analysis, including 134 with functional PNENs and 7616 with nonfunctional PNENs. Clinical feature and prognosis differences between functional and nonfunctional PNENs were compared. Independent prognostic factors affecting CSS were analyzed by univariate and multifactorial Cox regression. Nomogram and web-based prognosis prediction of PNENs were developed and validated by C indices, decision curve analysis, and calibration plots. Results Patients with functional PNENs were younger at diagnosis than those with nonfunctional PNENs. Functional PNENs had better prognoses than nonfunctional PNENs (5-year survival rates: 78.55% and 71.10%, respectively). Univariate and multifactorial Cox regression analyses showed that tumor infiltration (T), nodal metastasis (N), metastasis (M), tumor site, differentiation grade, age, marital status, and surgical treatment were independent prognostic risk factors for CSS, which were included in the prognostic nomogram and web-based prognosis calculator. The calibration plots and decision curve analysis showed that the nomogram had excellent prediction and clinical practical ability. The C indices for CSS in the training and validation cohorts were 0.848 (95% CI 0.838-0.8578) and 0.823 (95% CI 0.807-0.839), respectively. We scored all patients according to the nomogram and divided patients into three different risk groups. The prognosis of the low-risk population was significantly better than those of the middle- and high-risk populations based on Kaplan-Meier survival curve. Conclusion We analyzed the clinical features of PNENs and developed a convenient and web dynamic nomogram to predict CSS.
引用
收藏
页码:927 / 937
页数:11
相关论文
共 50 条
  • [1] Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms
    Z. Lu
    T. Li
    C. Liu
    Y. Zheng
    J. Song
    [J]. Journal of Endocrinological Investigation, 2023, 46 : 927 - 937
  • [2] Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms
    Liao, Tianbao
    Su, Tingting
    Huang, Lina
    Li, Bixun
    Feng, Lu-Huai
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (01) : 85 - 90
  • [3] Comment on: development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms
    Ke, Xindi
    Yang, Huayu
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (03) : 319 - 320
  • [4] Development and Validation a Survival Prediction Model and a Risk Stratification for Elderly Locally Advanced Breast Cancer
    Meng, Xiangdi
    Chang, Xiaolong
    Wang, Xiaoxiao
    Guo, Yinghua
    [J]. CLINICAL BREAST CANCER, 2022, 22 (07) : 681 - 689
  • [5] Validation of a Disease-Specific Survival Model for Resected Entero-Pancreatic Neuroendocrine Neoplasms
    Trimble, Liam
    Kelly, Bridget
    Fitzgerald, Timothy
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S274 - S275
  • [6] Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics
    Choi, Jin Ho
    Paik, Woo Hyun
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (24)
  • [7] Development and validation of a risk prediction model for pancreatic cancer: PANCPRO
    Klein, AP
    Wang, W
    Chen, S
    Parmigiani, G
    [J]. GENETIC EPIDEMIOLOGY, 2005, 29 (03) : 258 - 259
  • [8] Development and Validation of a Novel Machine Learning Model to Predict the Survival of Patients with Gastrointestinal Neuroendocrine Neoplasms
    Liu, Si
    Chen, Yun-Xiang
    Dai, Bing
    Chen, Li
    [J]. NEUROENDOCRINOLOGY, 2024, 114 (08) : 733 - 748
  • [9] Prediction of survival and tumor recurrence in patients undergoing surgery for pancreatic neuroendocrine neoplasms
    Kaltenborn, Alexander
    Matzke, Svenja
    Kleine, Moritz
    Krech, Till
    Ramackers, Wolf
    Vondran, Florian W. R.
    Klempnauer, Juergen
    Bektas, Hueseyin
    Schrem, Harald
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2016, 113 (02) : 194 - 202
  • [10] Development and Validation of a Prediction Model to Estimate Individual Risk of Pancreatic Cancer
    Yu, Ami
    Woo, Sang Myung
    Joo, Jungnam
    Yang, Hye-Ryung
    Lee, Woo Jin
    Park, Sang-Jae
    Nam, Byung-Ho
    [J]. PLOS ONE, 2016, 11 (01):